Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

BACKGROUND: The BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical trials and are now being used in national vaccination programmes in the UK and several other countries. Studying the real-world effe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet
Main Authors: Vasileiou, Eleftheria, Simpson, Colin R, Shi, Ting, Kerr, Steven, Agrawal, Utkarsh, Akbari, Ashley, Bedston, Stuart, Beggs, Jillian, Bradley, Declan, Chuter, Antony, de Lusignan, Simon, Docherty, Annemarie B, Ford, David, Hobbs, FD Richard, Joy, Mark, Katikireddi, Srinivasa Vittal, Marple, James, McCowan, Colin, McGagh, Dylan, McMenamin, Jim, Moore, Emily, Murray, Josephine LK, Pan, Jiafeng, Ritchie, Lewis, Shah, Syed Ahmar, Stock, Sarah, Torabi, Fatemeh, Tsang, Ruby SM, Wood, Rachael, Woolhouse, Mark, Robertson, Chris, Sheikh, Aziz
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064669/
https://ncbi.nlm.nih.gov/pubmed/33901420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(21)00677-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados